Fact check: Dr. Thomas Seyfried proposes 'metabolic therapy' targeting glucose and glutamine as the two main fuels for cancer cells.
Verdict: mostly true — Trust Score 70/100
This post reported by peer-reviewed studies in 'Nutrition & Metabolism' and interviews on 'The Diary of a CEO'. While the content accurately reflects Dr. Thomas Seyfried's scientific thesis, the account sharing it is associated with consumer complaints, and the medical claims remain a minority view in oncology.
- Platform
- Source author
- longevityxlab — see all fact-checks of this account
- Original post
- https://www.instagram.com/p/DXrlZHyiKNF/?igsh=MXhmc3A2eDE3emJtcA==
- Verified on
- May 9, 2026
- Verification ID
- oa0nQG6JUfKK2xXeB2cKGQ
Original content reviewed
Platform: INSTAGRAM Author: @longevityxlab --- Caption/Description --- Most people think cancer is purely genetic, but research shows metabolism plays a massive role in how tumors grow. In fact, one of the earliest studies demonstrated that high blood sugar accelerates tumor growth, while lowering glucose slows it down. This is why scientists like Thomas Seyfried have proposed “metabolic therapy”, targeting the two main fuels cancer cells rely on: Glucose and glutamine. By lowering carbohydrate intake, fasting, and shifting into ketosis, the body produces ketones that healthy cells can use—but cancer cells can’t. Over time, this can stress tumor cells, cut off their fuel supply, and shrink their blood vessels. Important note: This is still an emerging area of research and not a replacement for medical treatment. But it raises a powerful question—what if nutrition and metabolism are as important in cancer therapy as drugs and radiation? Credits: @thomasseyfriedbc @thediaryofaceopodcast - Not medical advice. This post doesn’t guarantee the prevention of cancer. Always consult with your professional before starting any new treatment. --- Carousel/Slides (2 items) --- Slide 1 (image): Text: LONGEVITY LAB WORLD CLASS CANCER DOCTOR REVEALS THE ONLY 2 WAYS TO PREVENT CANCER CELLS FROM GROWING FAST... SHARE THIS TO YOUR LOVED ONES Slide 2 (video): Audio: [Background Music - Not Narration] Cancer is very preventable. It's just that we're doing everything we possibly can to induce it. We published one of the first ever papers linking that the higher your blood sugar, the faster the tumor grows. The lower the blood sugar, the slower the tumor grows. Undeniable. From a normal cell to a cancer cell doesn't happen overnight. All we have to know with cancer is how are they growing so rapidly? Why are they going out of control? How come it's so hard to kill them? A solution to the cancer problem without toxicity is to simultaneously restrict the t
Claims analyzed (4)
- verified: Dr. Thomas Seyfried proposes 'metabolic therapy' targeting glucose and glutamine as the two main fuels for cancer cells.
Dr. Seyfried has extensively published on his 'Press-Pulse' therapy, which specifically identifies glucose and glutamine as the primary fermentable fuels driving tumor growth. - mostly true: High blood sugar accelerates tumor growth, while lowering glucose slows it down.
This is a core tenet of the Warburg Effect and Seyfried's research. While generally true for many aggressive cancers (like glioblastoma), the effect varies by cancer type. - mixed: Cancer cells cannot utilize ketones for energy, while healthy cells can.
Seyfried argues that defective mitochondria prevent cancer cells from using ketones. However, some studies suggest certain cancer cells can adapt to use ketones, making this a point of scientific debate. - mostly true: Lowering carbohydrate intake, fasting, and ketosis can stress tumor cells and shrink their blood vessels.
Preclinical studies in mice have shown that calorie-restricted ketogenic diets have anti-angiogenic (blood vessel shrinking) effects, though human clinical evidence is still emerging.
Sources consulted (7)
- Press-pulse: a novel therapeutic strategy for the metabolic management of cancer — NIH / Nutrition & Metabolism
- The Groundbreaking Cancer Expert: Dr Thomas Seyfried — The Diary Of A CEO
- Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade — NIH / PMC
- Update on Thomas Seyfried and the Metabolic Theory of Cancer — Jeffrey Dach MD
- The calorically restricted ketogenic diet has anti-tumor and anti-angiogenic effects — NIH / PubMed
- Metabolic changes and anti-tumor effects of a ketogenic diet in a glioblastoma mouse model — NIH / PMC
- The Diary Of A CEO with Steven Bartlett Transcript — Happy Scribe
Related verifications
- Donald Trump updated a 1948 presidential ranking in August 2026. — Verified 90/100instagram · view post ↗
The Instagram post accurately reports that Donald Trump updated a 1948 presidential ranking in August 2026, placing himself in the "Greatest" tier and relegating Ulysses S. Grant and Jimmy Carter to t…
- Former Optum senior director Karan Gupta was sentenced to 3 years in prison. — Mostly true 65/100instagram · view post ↗
The post accurately states that former Optum senior director Karan Gupta was sentenced to three years in prison for his involvement in a $1.2 million "Ghost Employee" scam. This information is confirm…
- The video depicts a large, red and black bipedal robot, with a man in a black shirt and g… — Mostly true 65/100instagram · view post ↗
The Instagram post accurately depicts the Unitree GD01, a real, pilotable mecha robot that was unveiled in May 2026. The video shows the robot walking, interacting with a smaller robot, and breaking t…
- Chris Brown has been ordered to pay $12.9 million to former housekeeper Maria Avila after… — Mostly true 79/100instagram · view post ↗
The Instagram post accurately reports that Chris Brown was ordered to pay $12.9 million to his former housekeeper Maria Avila after a Los Angeles jury found him liable for a 2020 dog attack at his Tar…
- Michael Burry re-established out-of-the-money put options against Palantir this week. — Mostly true 75/100instagram · view post ↗
The Instagram post accurately states that Michael Burry has re-established out-of-the-money put options against Palantir, with contracts expiring in March 2027, and that he argues the stock's true lon…
AI-generated analysis. Not a substitute for professional fact-checking.